Skip to content

Effect of systemic orofacial myofunctional therapy on sleep quality after oral cancer flap transplantation and correlation of OSA

Effect of systemic orofacial myofunctional therapy on sleep quality after oral cancer flap transplantation and correlation of OSA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096935
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-27
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After oral cancer flap transplantation

Interventions

Postoperative routine treatment group:routine treatment
Postoperative systemic orofacial myofunctional therapy group:systemic orofacial myofunctional therapy

Sponsors

The Affiliated Stomatological Hospital of GuangXi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 18 years >= Age <=60 years; 2. Patients who were pathologically diagnosed as oral cancer and with flap transplantation.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiopulmonary, neuromuscular, liver and kidney diseases, tumors, etc. can not complete rehabilitation training; 2. Combined with mental disorders can not cooperate with treatment; 3. Combined with severe mandibular retraction, deviated nasal septum, chronic sinusitis, asthma and other upper airway obstruction diseases; 4. Obese patient, BMI>30.

Design outcomes

Primary

MeasureTime frame
Apnea-Hypopnea Index, AHI;Insomnia Severity Index, ISI;Airway morphology;Lowest SaO2;

Secondary

MeasureTime frame
Epworth Sleepiness Scale, ESS;Pittsburgh Sleep Quality Index, PSQI;

Countries

China

Contacts

Public ContactFengchun Liao

The Affiliated Stomatological Hospital of Guangxi Medical University

972118283@qq.com+86 771 5358419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026